[Retracted] METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m⁶A Modification

Figure 1

METTL3 was upregulated in BCa and predicted poor prognosis. (a) METTL3 mRNA levels in BCa tissues and paracancerous ones. (b) METTL3 protein levels in BCa tissues and paracancerous ones. (c) METTL3 levels in BCa patients with T1-T2 or T3-T4. (d) METTL3 levels in BCa patients either with lymphatic metastasis or not. (e) The overall survivals in 2 groups of BCa patients.

(a)

(b)

(c)

(d)

(e)